Globus Medical, Inc.
GMED
Classement en actions
#1976
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Prix de l'action
$78.67
Capitalisation boursière
$10.56B
Changement (1 jour)
-0.49%
Changement (1 an)
25.40%
Pays
US
Échange Globus Medical, Inc. (GMED)
Catégorie
Healthcare
Revenus pour Globus Medical, Inc. (GMED)
Revenus en Jun 2026 TTM : $3.14B
Selon les derniers rapports financiers de Globus Medical, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $3.14B. En 2023, l'entreprise a réalisé un chiffre d'affaires de $1.57B une augmentation par rapport à le chiffre d'affaires de l'année 2022, qui était de $1.02B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Globus Medical, Inc. de 2009 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $3.14B | 24.83% |
| 2024 | $2.52B | 60.62% |
| 2023 | $1.57B | 53.34% |
| 2022 | $1.02B | 6.76% |
| 2021 | $958.10M | 21.43% |
| 2020 | $789.04M | 0.47% |
| 2019 | $785.37M | 10.15% |
| 2018 | $712.97M | 12.11% |
| 2017 | $635.98M | 12.76% |
| 2016 | $563.99M | 3.53% |
| 2015 | $544.75M | 14.84% |
| 2014 | $474.37M | 9.19% |
| 2013 | $434.46M | 12.56% |
| 2012 | $385.99M | 16.45% |
| 2011 | $331.48M | 15.02% |
| 2010 | $288.20M | 13.31% |
| 2009 | $254.34M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $46.59B | 1,381.29% |
US
|
|
| $35.48B | 1,028.30% |
IE
|
|
| $25.84B | 721.55% |
US
|
|
| $21.00B | 567.62% |
US
|
|
| - | - |
DE
|
